

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.67135863 |
| 2 | synaptic vesicle maturation (GO:0016188) | 5.64603966 |
| 3 | locomotory exploration behavior (GO:0035641) | 5.61459578 |
| 4 | central nervous system myelination (GO:0022010) | 5.53527041 |
| 5 | axon ensheathment in central nervous system (GO:0032291) | 5.53527041 |
| 6 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.35584137 |
| 7 | presynaptic membrane assembly (GO:0097105) | 5.14781521 |
| 8 | response to pheromone (GO:0019236) | 4.98857153 |
| 9 | synaptic vesicle exocytosis (GO:0016079) | 4.97934536 |
| 10 | presynaptic membrane organization (GO:0097090) | 4.89206874 |
| 11 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.87890529 |
| 12 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 4.82689318 |
| 13 | gamma-aminobutyric acid transport (GO:0015812) | 4.80775490 |
| 14 | L-amino acid import (GO:0043092) | 4.76966582 |
| 15 | * cellular potassium ion homeostasis (GO:0030007) | 4.74266624 |
| 16 | * sodium ion export (GO:0071436) | 4.59378364 |
| 17 | glutamate secretion (GO:0014047) | 4.55191668 |
| 18 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.54549633 |
| 19 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.48894274 |
| 20 | vocalization behavior (GO:0071625) | 4.43134914 |
| 21 | neurotransmitter secretion (GO:0007269) | 4.35049092 |
| 22 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.32466055 |
| 23 | cerebellar granule cell differentiation (GO:0021707) | 4.30856967 |
| 24 | retinal rod cell development (GO:0046548) | 4.29968244 |
| 25 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.24717814 |
| 26 | glutamate receptor signaling pathway (GO:0007215) | 4.19846491 |
| 27 | amino acid import (GO:0043090) | 4.19648097 |
| 28 | protein localization to synapse (GO:0035418) | 4.16666563 |
| 29 | layer formation in cerebral cortex (GO:0021819) | 4.10238670 |
| 30 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.05881003 |
| 31 | C4-dicarboxylate transport (GO:0015740) | 4.00835224 |
| 32 | regulation of synaptic vesicle transport (GO:1902803) | 4.00049237 |
| 33 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.96256274 |
| 34 | neuronal ion channel clustering (GO:0045161) | 3.96079797 |
| 35 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.93279536 |
| 36 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.92251530 |
| 37 | synaptic transmission, glutamatergic (GO:0035249) | 3.89789990 |
| 38 | neuronal action potential propagation (GO:0019227) | 3.88236589 |
| 39 | dendritic spine morphogenesis (GO:0060997) | 3.86624616 |
| 40 | * cell communication by electrical coupling (GO:0010644) | 3.81268631 |
| 41 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.80893266 |
| 42 | positive regulation of synapse maturation (GO:0090129) | 3.79381096 |
| 43 | response to auditory stimulus (GO:0010996) | 3.78633030 |
| 44 | * potassium ion homeostasis (GO:0055075) | 3.78519086 |
| 45 | exploration behavior (GO:0035640) | 3.77567528 |
| 46 | long-term memory (GO:0007616) | 3.76139219 |
| 47 | alanine transport (GO:0032328) | 3.75422393 |
| 48 | neurotransmitter transport (GO:0006836) | 3.74270464 |
| 49 | mechanosensory behavior (GO:0007638) | 3.73110377 |
| 50 | synaptic vesicle endocytosis (GO:0048488) | 3.66611598 |
| 51 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.63636874 |
| 52 | glycine transport (GO:0015816) | 3.61239281 |
| 53 | positive regulation of dendritic spine development (GO:0060999) | 3.60013124 |
| 54 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.58367224 |
| 55 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.57724985 |
| 56 | neuron-neuron synaptic transmission (GO:0007270) | 3.55889902 |
| 57 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.55139437 |
| 58 | * cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.52331705 |
| 59 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.51718763 |
| 60 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.44959098 |
| 61 | neuron cell-cell adhesion (GO:0007158) | 3.43270283 |
| 62 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.42327221 |
| 63 | * potassium ion import (GO:0010107) | 3.42044278 |
| 64 | retinal cone cell development (GO:0046549) | 3.41628463 |
| 65 | neuromuscular process controlling posture (GO:0050884) | 3.40808626 |
| 66 | membrane hyperpolarization (GO:0060081) | 3.36236642 |
| 67 | regulation of synapse structural plasticity (GO:0051823) | 3.35663828 |
| 68 | cerebellar Purkinje cell layer development (GO:0021680) | 3.35057669 |
| 69 | regulation of neurotransmitter levels (GO:0001505) | 3.34603941 |
| 70 | detection of light stimulus involved in visual perception (GO:0050908) | 3.33713333 |
| 71 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.33713333 |
| 72 | innervation (GO:0060384) | 3.33404977 |
| 73 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.32792641 |
| 74 | acidic amino acid transport (GO:0015800) | 3.32257898 |
| 75 | regulation of neurotransmitter secretion (GO:0046928) | 3.30414868 |
| 76 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.29884557 |
| 77 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.27821852 |
| 78 | regulation of synaptic plasticity (GO:0048167) | 3.26712224 |
| 79 | cell differentiation in hindbrain (GO:0021533) | 3.26445509 |
| 80 | proline transport (GO:0015824) | 3.24866542 |
| 81 | dendrite morphogenesis (GO:0048813) | 3.22104368 |
| 82 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.20727492 |
| 83 | long-term synaptic potentiation (GO:0060291) | 3.20697786 |
| 84 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.20530705 |
| 85 | auditory behavior (GO:0031223) | 3.19889446 |
| 86 | transmission of nerve impulse (GO:0019226) | 3.19736305 |
| 87 | membrane depolarization during action potential (GO:0086010) | 3.19078853 |
| 88 | regulation of ARF protein signal transduction (GO:0032012) | 3.17601016 |
| 89 | positive regulation of membrane potential (GO:0045838) | 3.17461491 |
| 90 | neuron recognition (GO:0008038) | 3.17290011 |
| 91 | regulation of dendritic spine development (GO:0060998) | 3.15427630 |
| 92 | axonal fasciculation (GO:0007413) | 3.15375280 |
| 93 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.15282191 |
| 94 | regulation of neurotransmitter transport (GO:0051588) | 3.14271039 |
| 95 | * cellular sodium ion homeostasis (GO:0006883) | 3.14219429 |
| 96 | photoreceptor cell development (GO:0042461) | 3.12951691 |
| 97 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.12122862 |
| 98 | neuromuscular process controlling balance (GO:0050885) | 3.11277424 |
| 99 | membrane depolarization (GO:0051899) | 3.10515193 |
| 100 | L-glutamate transport (GO:0015813) | 3.07782549 |
| 101 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.07235300 |
| 102 | regulation of membrane repolarization (GO:0060306) | 3.07230304 |
| 103 | neuromuscular synaptic transmission (GO:0007274) | 3.06703970 |
| 104 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.05911105 |
| 105 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.05715510 |
| 106 | establishment of mitochondrion localization (GO:0051654) | 3.05636399 |
| 107 | regulation of postsynaptic membrane potential (GO:0060078) | 3.05159065 |
| 108 | prepulse inhibition (GO:0060134) | 3.04417263 |
| 109 | eye photoreceptor cell development (GO:0042462) | 3.02875425 |
| 110 | regulation of respiratory system process (GO:0044065) | 3.01543714 |
| 111 | regulation of vesicle fusion (GO:0031338) | 2.99286856 |
| 112 | neurotransmitter uptake (GO:0001504) | 2.98724252 |
| 113 | postsynaptic membrane organization (GO:0001941) | 2.98314994 |
| 114 | response to histamine (GO:0034776) | 2.98084800 |
| 115 | regulation of synaptic transmission (GO:0050804) | 2.97824409 |
| 116 | astrocyte differentiation (GO:0048708) | 2.96845116 |
| 117 | positive regulation of synapse assembly (GO:0051965) | 2.91402173 |
| 118 | adult walking behavior (GO:0007628) | 2.90725188 |
| 119 | synapse assembly (GO:0007416) | 2.88714312 |
| 120 | regulation of synapse maturation (GO:0090128) | 2.87883537 |
| 121 | regulation of beta-amyloid formation (GO:1902003) | 2.87528820 |
| 122 | rhodopsin mediated signaling pathway (GO:0016056) | 2.86594246 |
| 123 | synaptic transmission (GO:0007268) | 2.86410516 |
| 124 | regulation of neurotransmitter uptake (GO:0051580) | 2.86278779 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.46510446 |
| 2 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.09747727 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.93657150 |
| 4 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.92093589 |
| 5 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.89619553 |
| 6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.74528502 |
| 7 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.68553771 |
| 8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.67108717 |
| 9 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.67108717 |
| 10 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.61488325 |
| 11 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.58878431 |
| 12 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.56655717 |
| 13 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.55315962 |
| 14 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.49578930 |
| 15 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.32958235 |
| 16 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.32829104 |
| 17 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.31608365 |
| 18 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.29778468 |
| 19 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.29204750 |
| 20 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.23225127 |
| 21 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.21714908 |
| 22 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.21047554 |
| 23 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.19913759 |
| 24 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.18964099 |
| 25 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.18696942 |
| 26 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.12978603 |
| 27 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.98364545 |
| 28 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.91402471 |
| 29 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.87207718 |
| 30 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.67110229 |
| 31 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.61300778 |
| 32 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.57359404 |
| 33 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.44786774 |
| 34 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.44514921 |
| 35 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.43648979 |
| 36 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.41712504 |
| 37 | AR_19668381_ChIP-Seq_PC3_Human | 1.40565959 |
| 38 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.34123378 |
| 39 | KDM2B_26808549_Chip-Seq_K562_Human | 1.33908156 |
| 40 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.32190657 |
| 41 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.32118786 |
| 42 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.30509631 |
| 43 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.30387344 |
| 44 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.30312217 |
| 45 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.29383237 |
| 46 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.28309552 |
| 47 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.26992877 |
| 48 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.25535670 |
| 49 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.25387185 |
| 50 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.22453784 |
| 51 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.19890935 |
| 52 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.19429603 |
| 53 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.18607892 |
| 54 | AR_25329375_ChIP-Seq_VCAP_Human | 1.16320616 |
| 55 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.15819726 |
| 56 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.14736041 |
| 57 | STAT3_23295773_ChIP-Seq_U87_Human | 1.13965074 |
| 58 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.12132565 |
| 59 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.12093428 |
| 60 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.10561777 |
| 61 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.10307966 |
| 62 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.09579265 |
| 63 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.09453207 |
| 64 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.08829078 |
| 65 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.08148404 |
| 66 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.07890053 |
| 67 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.07804647 |
| 68 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.07324849 |
| 69 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.07225319 |
| 70 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.07225319 |
| 71 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07020949 |
| 72 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.06603732 |
| 73 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.06298491 |
| 74 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.05831264 |
| 75 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04146606 |
| 76 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.02397351 |
| 77 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.02037532 |
| 78 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.01943758 |
| 79 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.01883402 |
| 80 | RXR_22108803_ChIP-Seq_LS180_Human | 1.01229763 |
| 81 | TP53_16413492_ChIP-PET_HCT116_Human | 1.00492957 |
| 82 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.00013750 |
| 83 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.99636952 |
| 84 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99268399 |
| 85 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.98662074 |
| 86 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.98273429 |
| 87 | TCF4_23295773_ChIP-Seq_U87_Human | 0.97952814 |
| 88 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.97897437 |
| 89 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.96643567 |
| 90 | P300_19829295_ChIP-Seq_ESCs_Human | 0.96328269 |
| 91 | * CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.96123402 |
| 92 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.95528530 |
| 93 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.94593439 |
| 94 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.93653284 |
| 95 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.93341443 |
| 96 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.93149138 |
| 97 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.92298598 |
| 98 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.91089634 |
| 99 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.90323780 |
| 100 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.89943867 |
| 101 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.89828380 |
| 102 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.89654832 |
| 103 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.89241462 |
| 104 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.88319657 |
| 105 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.88296477 |
| 106 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.88076200 |
| 107 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.87686417 |
| 108 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.87492871 |
| 109 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.87106860 |
| 110 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.87106132 |
| 111 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.85030555 |
| 112 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.85018378 |
| 113 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.84406575 |
| 114 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.83893234 |
| 115 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.83777785 |
| 116 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.83617184 |
| 117 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.83598704 |
| 118 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.83442418 |
| 119 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.82915418 |
| 120 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.82844821 |
| 121 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.82741747 |
| 122 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.81557773 |
| 123 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.80848397 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.00020128 |
| 2 | MP0005551_abnormal_eye_electrophysiolog | 3.89345397 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.55093038 |
| 4 | MP0009046_muscle_twitch | 3.41199809 |
| 5 | MP0003880_abnormal_central_pattern | 3.21807523 |
| 6 | MP0005423_abnormal_somatic_nervous | 3.15514951 |
| 7 | MP0002064_seizures | 2.83622007 |
| 8 | MP0004270_analgesia | 2.77150077 |
| 9 | MP0001486_abnormal_startle_reflex | 2.75448482 |
| 10 | MP0009745_abnormal_behavioral_response | 2.74963936 |
| 11 | MP0002063_abnormal_learning/memory/cond | 2.62637424 |
| 12 | MP0004885_abnormal_endolymph | 2.46837363 |
| 13 | MP0002272_abnormal_nervous_system | 2.46212389 |
| 14 | MP0002572_abnormal_emotion/affect_behav | 2.30359861 |
| 15 | MP0001502_abnormal_circadian_rhythm | 2.27320157 |
| 16 | MP0003011_delayed_dark_adaptation | 2.26767491 |
| 17 | MP0002734_abnormal_mechanical_nocicepti | 2.26159132 |
| 18 | * MP0008569_lethality_at_weaning | 2.24434587 |
| 19 | MP0004858_abnormal_nervous_system | 2.22695476 |
| 20 | * MP0005253_abnormal_eye_physiology | 2.22569515 |
| 21 | MP0001968_abnormal_touch/_nociception | 2.20945124 |
| 22 | MP0003329_amyloid_beta_deposits | 2.15344320 |
| 23 | MP0003690_abnormal_glial_cell | 2.06260136 |
| 24 | MP0009780_abnormal_chondrocyte_physiolo | 2.05498270 |
| 25 | MP0001440_abnormal_grooming_behavior | 2.04660996 |
| 26 | MP0002090_abnormal_vision | 2.04143096 |
| 27 | MP0001984_abnormal_olfaction | 2.04026897 |
| 28 | MP0002638_abnormal_pupillary_reflex | 2.00846351 |
| 29 | * MP0006072_abnormal_retinal_apoptosis | 1.95971041 |
| 30 | * MP0002067_abnormal_sensory_capabilities | 1.95959675 |
| 31 | MP0005646_abnormal_pituitary_gland | 1.91510890 |
| 32 | MP0001501_abnormal_sleep_pattern | 1.81603008 |
| 33 | MP0002736_abnormal_nociception_after | 1.66375879 |
| 34 | MP0004145_abnormal_muscle_electrophysio | 1.62759703 |
| 35 | * MP0002229_neurodegeneration | 1.61126457 |
| 36 | MP0002909_abnormal_adrenal_gland | 1.61095751 |
| 37 | * MP0002882_abnormal_neuron_morphology | 1.59232974 |
| 38 | MP0002557_abnormal_social/conspecific_i | 1.58393284 |
| 39 | MP0003633_abnormal_nervous_system | 1.55948861 |
| 40 | MP0002184_abnormal_innervation | 1.55812524 |
| 41 | MP0002733_abnormal_thermal_nociception | 1.52244854 |
| 42 | MP0001970_abnormal_pain_threshold | 1.51419502 |
| 43 | MP0004142_abnormal_muscle_tone | 1.51016173 |
| 44 | MP0004924_abnormal_behavior | 1.49307461 |
| 45 | MP0005386_behavior/neurological_phenoty | 1.49307461 |
| 46 | MP0003136_yellow_coat_color | 1.48508164 |
| 47 | MP0004233_abnormal_muscle_weight | 1.47636624 |
| 48 | MP0003634_abnormal_glial_cell | 1.47150915 |
| 49 | MP0003122_maternal_imprinting | 1.44585904 |
| 50 | MP0000955_abnormal_spinal_cord | 1.44417483 |
| 51 | MP0000778_abnormal_nervous_system | 1.41818914 |
| 52 | MP0004215_abnormal_myocardial_fiber | 1.38755964 |
| 53 | * MP0005195_abnormal_posterior_eye | 1.35667034 |
| 54 | MP0003631_nervous_system_phenotype | 1.33834561 |
| 55 | MP0002653_abnormal_ependyma_morphology | 1.29690001 |
| 56 | MP0004811_abnormal_neuron_physiology | 1.29528127 |
| 57 | * MP0002066_abnormal_motor_capabilities/c | 1.26670365 |
| 58 | MP0003632_abnormal_nervous_system | 1.24760456 |
| 59 | MP0002735_abnormal_chemical_nociception | 1.23917745 |
| 60 | MP0003879_abnormal_hair_cell | 1.20448407 |
| 61 | MP0001529_abnormal_vocalization | 1.19716229 |
| 62 | * MP0002752_abnormal_somatic_nervous | 1.17912002 |
| 63 | MP0000566_synostosis | 1.17756538 |
| 64 | MP0000751_myopathy | 1.10259965 |
| 65 | * MP0002152_abnormal_brain_morphology | 1.09468447 |
| 66 | MP0002822_catalepsy | 1.07836909 |
| 67 | MP0005394_taste/olfaction_phenotype | 1.05305707 |
| 68 | MP0005499_abnormal_olfactory_system | 1.05305707 |
| 69 | MP0004147_increased_porphyrin_level | 1.04778863 |
| 70 | MP0002089_abnormal_postnatal_growth/wei | 1.04412912 |
| 71 | MP0003075_altered_response_to | 1.02916415 |
| 72 | MP0003137_abnormal_impulse_conducting | 1.02903487 |
| 73 | MP0005645_abnormal_hypothalamus_physiol | 1.02388812 |
| 74 | MP0004043_abnormal_pH_regulation | 1.00749070 |
| 75 | MP0004742_abnormal_vestibular_system | 0.97923021 |
| 76 | MP0000920_abnormal_myelination | 0.96455930 |
| 77 | MP0000026_abnormal_inner_ear | 0.94646859 |
| 78 | MP0000604_amyloidosis | 0.94514197 |
| 79 | MP0001986_abnormal_taste_sensitivity | 0.93279174 |
| 80 | MP0005167_abnormal_blood-brain_barrier | 0.93175837 |
| 81 | MP0001963_abnormal_hearing_physiology | 0.92838671 |
| 82 | MP0003950_abnormal_plasma_membrane | 0.92781560 |
| 83 | MP0003123_paternal_imprinting | 0.91522766 |
| 84 | MP0001324_abnormal_eye_pigmentation | 0.88745612 |
| 85 | * MP0005391_vision/eye_phenotype | 0.87715586 |
| 86 | MP0000579_abnormal_nail_morphology | 0.86891150 |
| 87 | MP0001485_abnormal_pinna_reflex | 0.86375023 |
| 88 | MP0003646_muscle_fatigue | 0.85911694 |
| 89 | MP0006292_abnormal_olfactory_placode | 0.83896954 |
| 90 | MP0000631_abnormal_neuroendocrine_gland | 0.82167139 |
| 91 | MP0003183_abnormal_peptide_metabolism | 0.81630647 |
| 92 | MP0008872_abnormal_physiological_respon | 0.80388166 |
| 93 | MP0002249_abnormal_larynx_morphology | 0.77686002 |
| 94 | MP0008877_abnormal_DNA_methylation | 0.77550123 |
| 95 | MP0005171_absent_coat_pigmentation | 0.77050084 |
| 96 | MP0001299_abnormal_eye_distance/ | 0.76673755 |
| 97 | MP0003121_genomic_imprinting | 0.75896898 |
| 98 | MP0001177_atelectasis | 0.71858264 |
| 99 | MP0003861_abnormal_nervous_system | 0.71730788 |
| 100 | MP0004085_abnormal_heartbeat | 0.71363262 |
| 101 | MP0003787_abnormal_imprinting | 0.71143432 |
| 102 | * MP0002069_abnormal_eating/drinking_beha | 0.70740645 |
| 103 | MP0003938_abnormal_ear_development | 0.70621291 |
| 104 | MP0008961_abnormal_basal_metabolism | 0.69419692 |
| 105 | MP0003172_abnormal_lysosome_physiology | 0.68970574 |
| 106 | MP0001188_hyperpigmentation | 0.65066734 |
| 107 | MP0001346_abnormal_lacrimal_gland | 0.64642333 |
| 108 | MP0004036_abnormal_muscle_relaxation | 0.64012994 |
| 109 | MP0005623_abnormal_meninges_morphology | 0.63262308 |
| 110 | MP0000013_abnormal_adipose_tissue | 0.62191308 |
| 111 | MP0006276_abnormal_autonomic_nervous | 0.61493138 |
| 112 | MP0005595_abnormal_vascular_smooth | 0.61310267 |
| 113 | MP0003283_abnormal_digestive_organ | 0.59564460 |
| 114 | MP0003045_fibrosis | 0.59213826 |
| 115 | MP0009384_cardiac_valve_regurgitation | 0.58181553 |
| 116 | MP0005535_abnormal_body_temperature | 0.57867495 |
| 117 | MP0001905_abnormal_dopamine_level | 0.57071681 |
| 118 | * MP0010769_abnormal_survival | 0.57058571 |
| 119 | MP0008874_decreased_physiological_sensi | 0.56652103 |
| 120 | MP0010770_preweaning_lethality | 0.55704038 |
| 121 | MP0002082_postnatal_lethality | 0.55704038 |
| 122 | MP0001943_abnormal_respiration | 0.55310895 |
| 123 | MP0004130_abnormal_muscle_cell | 0.54387346 |
| 124 | MP0000569_abnormal_digit_pigmentation | 0.53700206 |
| 125 | * MP0010768_mortality/aging | 0.53392994 |
| 126 | MP0005187_abnormal_penis_morphology | 0.51366187 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Congenital stationary night blindness (HP:0007642) | 6.71030308 |
| 2 | Central scotoma (HP:0000603) | 4.97177387 |
| 3 | Focal motor seizures (HP:0011153) | 4.89026648 |
| 4 | Progressive cerebellar ataxia (HP:0002073) | 4.77926238 |
| 5 | Action tremor (HP:0002345) | 4.42377749 |
| 6 | Epileptic encephalopathy (HP:0200134) | 4.41176013 |
| 7 | Visual hallucinations (HP:0002367) | 4.39036226 |
| 8 | Myokymia (HP:0002411) | 4.29970118 |
| 9 | Abnormality of macular pigmentation (HP:0008002) | 4.17665931 |
| 10 | Scotoma (HP:0000575) | 4.13648043 |
| 11 | Abnormal rod and cone electroretinograms (HP:0008323) | 4.09731429 |
| 12 | Megalencephaly (HP:0001355) | 4.05262892 |
| 13 | Focal seizures (HP:0007359) | 3.99877280 |
| 14 | Dysdiadochokinesis (HP:0002075) | 3.87872820 |
| 15 | Bony spicule pigmentary retinopathy (HP:0007737) | 3.84390553 |
| 16 | Hemiparesis (HP:0001269) | 3.77748332 |
| 17 | Hemiplegia (HP:0002301) | 3.69355048 |
| 18 | Febrile seizures (HP:0002373) | 3.50596693 |
| 19 | Supranuclear gaze palsy (HP:0000605) | 3.44864702 |
| 20 | Aplasia involving bones of the upper limbs (HP:0009823) | 3.44055802 |
| 21 | Aplasia of the phalanges of the hand (HP:0009802) | 3.44055802 |
| 22 | Aplasia involving bones of the extremities (HP:0009825) | 3.44055802 |
| 23 | Limb dystonia (HP:0002451) | 3.38028717 |
| 24 | Diplopia (HP:0000651) | 3.29783121 |
| 25 | Abnormality of binocular vision (HP:0011514) | 3.29783121 |
| 26 | Decreased central vision (HP:0007663) | 3.26637779 |
| 27 | Absence seizures (HP:0002121) | 3.24818445 |
| 28 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.23732957 |
| 29 | Peripheral hypomyelination (HP:0007182) | 3.21917340 |
| 30 | Severe visual impairment (HP:0001141) | 3.12146622 |
| 31 | Genetic anticipation (HP:0003743) | 3.09065717 |
| 32 | Generalized tonic-clonic seizures (HP:0002069) | 3.04494427 |
| 33 | Truncal ataxia (HP:0002078) | 3.02021121 |
| 34 | Gaze-evoked nystagmus (HP:0000640) | 3.01196740 |
| 35 | Depression (HP:0000716) | 3.01054942 |
| 36 | Postural instability (HP:0002172) | 2.98135036 |
| 37 | Annular pancreas (HP:0001734) | 2.96135379 |
| 38 | Obstructive sleep apnea (HP:0002870) | 2.92065770 |
| 39 | Dialeptic seizures (HP:0011146) | 2.92051361 |
| 40 | Abolished electroretinogram (ERG) (HP:0000550) | 2.88692381 |
| 41 | Increased circulating renin level (HP:0000848) | 2.88385917 |
| 42 | Atonic seizures (HP:0010819) | 2.84860828 |
| 43 | Cerebral hypomyelination (HP:0006808) | 2.82022765 |
| 44 | Intention tremor (HP:0002080) | 2.81259783 |
| 45 | Torticollis (HP:0000473) | 2.80494935 |
| 46 | Neurofibrillary tangles (HP:0002185) | 2.77463056 |
| 47 | Chorioretinal atrophy (HP:0000533) | 2.74180706 |
| 48 | Dyschromatopsia (HP:0007641) | 2.73027268 |
| 49 | Sleep apnea (HP:0010535) | 2.69229928 |
| 50 | Papilledema (HP:0001085) | 2.69158858 |
| 51 | Dysmetria (HP:0001310) | 2.67337332 |
| 52 | Status epilepticus (HP:0002133) | 2.62431009 |
| 53 | Abnormal eating behavior (HP:0100738) | 2.57644539 |
| 54 | Polyphagia (HP:0002591) | 2.55733781 |
| 55 | Hyperventilation (HP:0002883) | 2.55331972 |
| 56 | Abnormality of the corticospinal tract (HP:0002492) | 2.55082925 |
| 57 | Pendular nystagmus (HP:0012043) | 2.54542303 |
| 58 | Dysmetric saccades (HP:0000641) | 2.54098995 |
| 59 | Pigmentary retinal degeneration (HP:0001146) | 2.52364238 |
| 60 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.52091851 |
| 61 | Impaired smooth pursuit (HP:0007772) | 2.49863116 |
| 62 | Ankle clonus (HP:0011448) | 2.48540544 |
| 63 | Scanning speech (HP:0002168) | 2.47351373 |
| 64 | Increased corneal curvature (HP:0100692) | 2.37742080 |
| 65 | Keratoconus (HP:0000563) | 2.37742080 |
| 66 | Macular degeneration (HP:0000608) | 2.36579526 |
| 67 | Anxiety (HP:0000739) | 2.36191288 |
| 68 | Abnormality of the lower motor neuron (HP:0002366) | 2.34684856 |
| 69 | Insomnia (HP:0100785) | 2.34565198 |
| 70 | Mutism (HP:0002300) | 2.33750280 |
| 71 | Akinesia (HP:0002304) | 2.33015086 |
| 72 | Broad-based gait (HP:0002136) | 2.32225140 |
| 73 | Focal dystonia (HP:0004373) | 2.30458291 |
| 74 | Ventricular fibrillation (HP:0001663) | 2.26493787 |
| 75 | Urinary urgency (HP:0000012) | 2.25313734 |
| 76 | Attenuation of retinal blood vessels (HP:0007843) | 2.24540121 |
| 77 | Tetraplegia (HP:0002445) | 2.21110963 |
| 78 | Morphological abnormality of the inner ear (HP:0011390) | 2.18278033 |
| 79 | Cerebral inclusion bodies (HP:0100314) | 2.17817589 |
| 80 | Poor eye contact (HP:0000817) | 2.16149053 |
| 81 | Delusions (HP:0000746) | 2.15529408 |
| 82 | Bradykinesia (HP:0002067) | 2.14874317 |
| 83 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.14559622 |
| 84 | Choroideremia (HP:0001139) | 2.13018841 |
| 85 | Abnormal social behavior (HP:0012433) | 2.12200528 |
| 86 | Impaired social interactions (HP:0000735) | 2.12200528 |
| 87 | Posterior subcapsular cataract (HP:0007787) | 2.12010404 |
| 88 | Clumsiness (HP:0002312) | 2.11643668 |
| 89 | Spastic tetraparesis (HP:0001285) | 2.10226780 |
| 90 | Craniofacial dystonia (HP:0012179) | 2.08998675 |
| 91 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.08371267 |
| 92 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.08371267 |
| 93 | Type II diabetes mellitus (HP:0005978) | 2.08193935 |
| 94 | Exercise-induced myalgia (HP:0003738) | 2.05534532 |
| 95 | Bronchomalacia (HP:0002780) | 2.05366420 |
| 96 | Clonus (HP:0002169) | 2.04497664 |
| 97 | Photophobia (HP:0000613) | 2.03079130 |
| 98 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.02753979 |
| 99 | Absent speech (HP:0001344) | 2.01426683 |
| 100 | Limb ataxia (HP:0002070) | 2.00011381 |
| 101 | EEG with generalized epileptiform discharges (HP:0011198) | 1.96144130 |
| 102 | Prolonged QT interval (HP:0001657) | 1.96025664 |
| 103 | Postural tremor (HP:0002174) | 1.93363433 |
| 104 | Amblyopia (HP:0000646) | 1.92677193 |
| 105 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.92402878 |
| 106 | Epileptiform EEG discharges (HP:0011182) | 1.92240680 |
| 107 | Abnormality of the diencephalon (HP:0010662) | 1.90952750 |
| 108 | CNS hypomyelination (HP:0003429) | 1.89715382 |
| 109 | Turricephaly (HP:0000262) | 1.89462250 |
| 110 | Choreoathetosis (HP:0001266) | 1.86190621 |
| 111 | Gait imbalance (HP:0002141) | 1.85833873 |
| 112 | Rigidity (HP:0002063) | 1.85464000 |
| 113 | Thickened helices (HP:0000391) | 1.85229694 |
| 114 | Abnormality of saccadic eye movements (HP:0000570) | 1.84592205 |
| 115 | Split foot (HP:0001839) | 1.80363010 |
| 116 | Confusion (HP:0001289) | 1.79964554 |
| 117 | Horizontal nystagmus (HP:0000666) | 1.79222203 |
| 118 | Retinitis pigmentosa (HP:0000510) | 1.79163297 |
| 119 | Spastic gait (HP:0002064) | 1.78948744 |
| 120 | Lower limb muscle weakness (HP:0007340) | 1.77744122 |
| 121 | Specific learning disability (HP:0001328) | 1.76582961 |
| 122 | Narrow nasal bridge (HP:0000446) | 1.76506042 |
| 123 | Incomplete penetrance (HP:0003829) | 1.75169368 |
| 124 | Hypsarrhythmia (HP:0002521) | 1.74596924 |
| 125 | Apathy (HP:0000741) | 1.74467281 |
| 126 | Neoplasm of the heart (HP:0100544) | 1.74059130 |
| 127 | Drooling (HP:0002307) | 1.73465618 |
| 128 | Excessive salivation (HP:0003781) | 1.73465618 |
| 129 | Lower limb asymmetry (HP:0100559) | 1.72853203 |
| 130 | Gait ataxia (HP:0002066) | 1.72424967 |
| 131 | Impaired vibratory sensation (HP:0002495) | 1.72022627 |
| 132 | Abnormal EKG (HP:0003115) | 1.71600740 |
| 133 | Cone-rod dystrophy (HP:0000548) | 1.71333456 |
| 134 | Metabolic alkalosis (HP:0200114) | 1.71320079 |
| 135 | Abnormality of cochlea (HP:0000375) | 1.70754471 |
| 136 | Stereotypic behavior (HP:0000733) | 1.69630049 |
| 137 | Neuronal loss in central nervous system (HP:0002529) | 1.69265415 |
| 138 | Pointed chin (HP:0000307) | 1.63777461 |
| 139 | Pheochromocytoma (HP:0002666) | 1.63694823 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 3.28148307 |
| 2 | EPHA4 | 3.12558809 |
| 3 | NTRK2 | 2.96970371 |
| 4 | MAP3K4 | 2.82953164 |
| 5 | PHKG1 | 2.80016354 |
| 6 | PHKG2 | 2.80016354 |
| 7 | PAK6 | 2.59953793 |
| 8 | PRKD3 | 2.59223468 |
| 9 | MAP3K9 | 2.54657160 |
| 10 | LMTK2 | 2.52435069 |
| 11 | TNIK | 2.47835559 |
| 12 | MINK1 | 2.45524886 |
| 13 | MARK1 | 2.38807865 |
| 14 | STK38 | 2.14775867 |
| 15 | MAP2K7 | 2.05119608 |
| 16 | CAMKK1 | 2.02857377 |
| 17 | PINK1 | 1.91353590 |
| 18 | RIPK1 | 1.80452885 |
| 19 | PRPF4B | 1.74818939 |
| 20 | SGK494 | 1.66533174 |
| 21 | SGK223 | 1.66533174 |
| 22 | SGK2 | 1.59475846 |
| 23 | MAP2K4 | 1.52526793 |
| 24 | CAMKK2 | 1.52443628 |
| 25 | SGK3 | 1.45692649 |
| 26 | DAPK2 | 1.45682054 |
| 27 | PKN1 | 1.43276372 |
| 28 | PRKCG | 1.35618378 |
| 29 | CDK5 | 1.34552613 |
| 30 | WNK1 | 1.33433312 |
| 31 | KSR2 | 1.29435823 |
| 32 | NEK1 | 1.29155963 |
| 33 | MAPK13 | 1.25433542 |
| 34 | CAMK1G | 1.19955477 |
| 35 | NTRK1 | 1.18321853 |
| 36 | PRKCH | 1.16678495 |
| 37 | TYRO3 | 1.13141605 |
| 38 | DYRK1A | 1.09486657 |
| 39 | MAPK12 | 1.03537864 |
| 40 | CAMK1 | 1.00002857 |
| 41 | SIK2 | 0.98950532 |
| 42 | GRK5 | 0.95635827 |
| 43 | KSR1 | 0.94942820 |
| 44 | MUSK | 0.93056462 |
| 45 | NEK6 | 0.91551354 |
| 46 | CDK19 | 0.91434872 |
| 47 | LATS2 | 0.91167375 |
| 48 | CDK15 | 0.90792880 |
| 49 | CDC42BPA | 0.88721312 |
| 50 | CDK18 | 0.87341563 |
| 51 | TRIB3 | 0.86458788 |
| 52 | TNK2 | 0.84987117 |
| 53 | PLK2 | 0.84835896 |
| 54 | CASK | 0.83471340 |
| 55 | CDK14 | 0.81864104 |
| 56 | ARAF | 0.81751053 |
| 57 | UHMK1 | 0.81506969 |
| 58 | GRK1 | 0.80144982 |
| 59 | SGK1 | 0.80022759 |
| 60 | STK11 | 0.79911698 |
| 61 | CDK11A | 0.79538004 |
| 62 | FES | 0.78887627 |
| 63 | CAMK2A | 0.78236068 |
| 64 | PNCK | 0.77056979 |
| 65 | DYRK2 | 0.76839771 |
| 66 | MAP3K13 | 0.75785991 |
| 67 | CSNK1G2 | 0.75163993 |
| 68 | MAP3K7 | 0.74974521 |
| 69 | SIK1 | 0.74715861 |
| 70 | ALK | 0.73790034 |
| 71 | TAOK2 | 0.70273613 |
| 72 | PAK3 | 0.68078638 |
| 73 | RPS6KA3 | 0.67787519 |
| 74 | RET | 0.67421792 |
| 75 | CAMK1D | 0.66519517 |
| 76 | MAPK15 | 0.66159915 |
| 77 | CAMK2D | 0.65564906 |
| 78 | ROCK2 | 0.65018121 |
| 79 | CAMK2G | 0.63979762 |
| 80 | BRSK1 | 0.63168990 |
| 81 | IRAK2 | 0.61832041 |
| 82 | DAPK1 | 0.59577226 |
| 83 | ICK | 0.59390063 |
| 84 | MAPK10 | 0.59321790 |
| 85 | PRKAA1 | 0.59231791 |
| 86 | CAMK4 | 0.58394828 |
| 87 | WNK3 | 0.56034610 |
| 88 | CCNB1 | 0.55577464 |
| 89 | OXSR1 | 0.55440670 |
| 90 | BMX | 0.55343318 |
| 91 | TAOK1 | 0.53814314 |
| 92 | RAF1 | 0.53690908 |
| 93 | MAPKAPK5 | 0.52147962 |
| 94 | MAPK7 | 0.51038322 |
| 95 | ROCK1 | 0.50908335 |
| 96 | PRKCZ | 0.50245026 |
| 97 | MARK2 | 0.49984640 |
| 98 | CDK3 | 0.48308714 |
| 99 | RIPK4 | 0.48209056 |
| 100 | PRKCE | 0.47528516 |
| 101 | CAMK2B | 0.47237645 |
| 102 | PDK1 | 0.45296178 |
| 103 | PRKCB | 0.44878509 |
| 104 | ERBB2 | 0.44201451 |
| 105 | PRKG1 | 0.43523384 |
| 106 | PRKCA | 0.42811390 |
| 107 | ADRBK1 | 0.42272139 |
| 108 | MAP3K2 | 0.41949927 |
| 109 | PRKACG | 0.41599227 |
| 110 | DMPK | 0.40989724 |
| 111 | GSK3B | 0.40553314 |
| 112 | FGFR2 | 0.40537228 |
| 113 | FGFR1 | 0.40100735 |
| 114 | STK39 | 0.37336020 |
| 115 | PRKACA | 0.36531612 |
| 116 | CSNK1A1 | 0.35639298 |
| 117 | LIMK1 | 0.34603975 |
| 118 | CSNK1A1L | 0.34487172 |
| 119 | FYN | 0.34107036 |
| 120 | CSNK1G3 | 0.33740532 |
| 121 | PRKDC | 0.32428374 |
| 122 | CSNK1D | 0.32251408 |
| 123 | MAPK4 | 0.31547975 |
| 124 | CSNK1G1 | 0.28056433 |
| 125 | CSNK1E | 0.27717430 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.68849000 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.67530037 |
| 3 | Phototransduction_Homo sapiens_hsa04744 | 3.38559303 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 3.06476258 |
| 5 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.06411397 |
| 6 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.62795649 |
| 7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.54602104 |
| 8 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.53858984 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.44885851 |
| 10 | Olfactory transduction_Homo sapiens_hsa04740 | 2.30988023 |
| 11 | Long-term potentiation_Homo sapiens_hsa04720 | 2.01790097 |
| 12 | * Salivary secretion_Homo sapiens_hsa04970 | 1.95654584 |
| 13 | * Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.93494857 |
| 14 | * Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.93082950 |
| 15 | * Insulin secretion_Homo sapiens_hsa04911 | 1.90249385 |
| 16 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.66595655 |
| 17 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.66359021 |
| 18 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.65942999 |
| 19 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.65185675 |
| 20 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.64203621 |
| 21 | * Gastric acid secretion_Homo sapiens_hsa04971 | 1.63618664 |
| 22 | Taste transduction_Homo sapiens_hsa04742 | 1.51170292 |
| 23 | * Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.48029647 |
| 24 | Long-term depression_Homo sapiens_hsa04730 | 1.47944255 |
| 25 | Circadian rhythm_Homo sapiens_hsa04710 | 1.47001670 |
| 26 | Renin secretion_Homo sapiens_hsa04924 | 1.46865549 |
| 27 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.43004034 |
| 28 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.41833083 |
| 29 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.34642902 |
| 30 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.30661234 |
| 31 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.26459292 |
| 32 | Cocaine addiction_Homo sapiens_hsa05030 | 1.25745224 |
| 33 | * cAMP signaling pathway_Homo sapiens_hsa04024 | 1.22915106 |
| 34 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.20394718 |
| 35 | * Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.15903932 |
| 36 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.15228544 |
| 37 | Gap junction_Homo sapiens_hsa04540 | 1.12840172 |
| 38 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.12287784 |
| 39 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.08977509 |
| 40 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.04763748 |
| 41 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.04737286 |
| 42 | * cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.98793580 |
| 43 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.97023240 |
| 44 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.94998259 |
| 45 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.92786930 |
| 46 | Prion diseases_Homo sapiens_hsa05020 | 0.87920080 |
| 47 | * Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.86028345 |
| 48 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.85284946 |
| 49 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.84759628 |
| 50 | * Pancreatic secretion_Homo sapiens_hsa04972 | 0.84375815 |
| 51 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.83218375 |
| 52 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.83035567 |
| 53 | Melanogenesis_Homo sapiens_hsa04916 | 0.80941563 |
| 54 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.77710560 |
| 55 | * Bile secretion_Homo sapiens_hsa04976 | 0.77277067 |
| 56 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.76203521 |
| 57 | * Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.75420381 |
| 58 | Glioma_Homo sapiens_hsa05214 | 0.72481050 |
| 59 | Histidine metabolism_Homo sapiens_hsa00340 | 0.68821206 |
| 60 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.68404161 |
| 61 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.67552131 |
| 62 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.65672941 |
| 63 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.65468028 |
| 64 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.64881160 |
| 65 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.64119252 |
| 66 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.64077017 |
| 67 | * Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.63697993 |
| 68 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.63681995 |
| 69 | Axon guidance_Homo sapiens_hsa04360 | 0.62024597 |
| 70 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.61591023 |
| 71 | * Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.59941071 |
| 72 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.59782636 |
| 73 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.58895583 |
| 74 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.58102685 |
| 75 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.57283847 |
| 76 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.56640313 |
| 77 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.52767314 |
| 78 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.52310510 |
| 79 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.51657303 |
| 80 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.51605955 |
| 81 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.50297926 |
| 82 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.49944665 |
| 83 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.49642934 |
| 84 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.49158341 |
| 85 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.47810813 |
| 86 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.47612420 |
| 87 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.46142437 |
| 88 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.40795613 |
| 89 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.40774346 |
| 90 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.40639644 |
| 91 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.40116415 |
| 92 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.39859543 |
| 93 | Alzheimers disease_Homo sapiens_hsa05010 | 0.39717303 |
| 94 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.39119153 |
| 95 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.38539896 |
| 96 | Endocytosis_Homo sapiens_hsa04144 | 0.37522640 |
| 97 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.35375460 |
| 98 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.35288591 |
| 99 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.35077291 |
| 100 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.35064271 |
| 101 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.34751062 |
| 102 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.32720376 |
| 103 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.32454665 |
| 104 | Alcoholism_Homo sapiens_hsa05034 | 0.32346245 |
| 105 | Endometrial cancer_Homo sapiens_hsa05213 | 0.32320507 |
| 106 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.30966811 |
| 107 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.30153125 |
| 108 | Tight junction_Homo sapiens_hsa04530 | 0.29485324 |
| 109 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.28951592 |
| 110 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.27965610 |
| 111 | * Mineral absorption_Homo sapiens_hsa04978 | 0.26050516 |
| 112 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.25249193 |
| 113 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.22381165 |
| 114 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.21621974 |

